Andreas Schildan

1.3k total citations
31 papers, 473 citations indexed

About

Andreas Schildan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andreas Schildan has authored 31 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andreas Schildan's work include Nicotinic Acetylcholine Receptors Study (15 papers), Medical Imaging Techniques and Applications (9 papers) and Receptor Mechanisms and Signaling (8 papers). Andreas Schildan is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (15 papers), Medical Imaging Techniques and Applications (9 papers) and Receptor Mechanisms and Signaling (8 papers). Andreas Schildan collaborates with scholars based in Germany, Netherlands and United States. Andreas Schildan's co-authors include Osama Sabri, Marianne Patt, Georg Becker, Henryk Barthel, Philipp Meyer, Swen Hesse, Dietlind Sorger, Kai Kendziorra, Peter Brust and Julia Luthardt and has published in prestigious journals such as NeuroImage, Journal of Cerebral Blood Flow & Metabolism and Journal of Nuclear Medicine.

In The Last Decade

Andreas Schildan

27 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Schildan Germany	11	198	172	148	131	112	31	473
Tyler E. Benedum United States	7	202 1.0×	145 0.8×	344 2.3×	158 1.2×	49 0.4×	8	634
Dnyanesh Tipre United States	15	180 0.9×	205 1.2×	136 0.9×	52 0.4×	160 1.4×	23	636
Aniket Joshi United States	10	67 0.3×	218 1.3×	119 0.8×	145 1.1×	82 0.7×	27	474
Nicolas J. Guehl United States	13	110 0.6×	208 1.2×	164 1.1×	97 0.7×	102 0.9×	48	570
Caroline Papin United States	13	278 1.4×	117 0.7×	177 1.2×	104 0.8×	191 1.7×	30	607
Florian Montel Germany	9	153 0.8×	62 0.4×	65 0.4×	62 0.5×	170 1.5×	16	407
Sandra Sanabria United States	12	196 1.0×	114 0.7×	72 0.5×	53 0.4×	151 1.3×	30	456
Evan Baum United States	6	117 0.6×	104 0.6×	118 0.8×	94 0.7×	204 1.8×	8	455
Solveig Tiepolt Germany	15	57 0.3×	273 1.6×	153 1.0×	188 1.4×	56 0.5×	35	539
André Manook Germany	12	122 0.6×	74 0.4×	204 1.4×	75 0.6×	58 0.5×	16	504

Countries citing papers authored by Andreas Schildan

Since Specialization

Citations

This map shows the geographic impact of Andreas Schildan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Schildan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Schildan more than expected).

Fields of papers citing papers by Andreas Schildan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Schildan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Schildan. The network helps show where Andreas Schildan may publish in the future.

Co-authorship network of co-authors of Andreas Schildan

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Schildan. A scholar is included among the top collaborators of Andreas Schildan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Schildan. Andreas Schildan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henssen, Dylan, Michael Rullmann, Andreas Schildan, et al.. (2025). Retrospective Evaluation of Baseline Amino Acid PET for Identifying Future Regions of Tumor Recurrence in High-Grade Glioma Patients. Cancers. 17(12). 1986–1986.

Henssen, Dylan, Michael Rullmann, Anne I.J. Arens, et al.. (2025). Biological tumor volume predicts survival in recurrent High-Grade glioma: A multiparametric [18F]FET PET/MRI study. European Journal of Nuclear Medicine and Molecular Imaging. 53(2). 833–842.

Rullmann, Michael, Simon Schmitt, Franziska Zientek, et al.. (2025). Abnormalities of iron homeostasis and the dopaminergic system in Tourette syndrome revealed by 7T MRI and PET. Brain Communications. 7(2). fcaf104–fcaf104. 1 indexed citations

Roeber, Sigrun, Anja K. E. Horn, Thomas Arzberger, et al.. (2021). Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [18F]PI-2620. Frontiers in Neurology. 12. 684523–684523. 9 indexed citations

Barthel, Henryk, Matthias Brendel, Thilo van Eimeren, et al.. (2021). Potential of F-18-PI-2620 Tau PET to Improve the Imaging-Based Diagnosis of Progressive Supranuclear Palsy (PSP). Nuklearmedizin - NuclearMedicine. 1 indexed citations

Brendel, Matthias, Christian Zach, Erik Mille, et al.. (2016). Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases. NeuroImage Clinical. 14. 77–86. 85 indexed citations

Kranz, Mathias, Bernhard Sattler, Solveig Tiepolt, et al.. (2016). Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results. EJNMMI Physics. 3(1). 25–25. 15 indexed citations

Patt, Marianne, Georg Becker, Andreas Schildan, et al.. (2014). Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (−)-[18F]Flubatine in humans. Nuclear Medicine and Biology. 41(6). 489–494. 12 indexed citations

Patt, Marianne, Andreas Schildan, Steffen Fischer, et al.. (2013). Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application. Applied Radiation and Isotopes. 80. 7–11. 15 indexed citations

10.

Patt, Marianne, et al.. (2013). Influence of additives to the formulation of n.c.a. [11C]PiB on sterile filter performance. Applied Radiation and Isotopes. 82. 289–292. 1 indexed citations

11.

Barthel, Henryk, Julia Luthardt, Georg Becker, et al.. (2011). Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls. European Journal of Nuclear Medicine and Molecular Imaging. 38(9). 1702–1714. 84 indexed citations

12.

Kendziorra, Kai, Henrike Wolf, Philipp Meyer, et al.. (2010). Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 38(3). 515–525. 80 indexed citations

13.

Schildan, Andreas, et al.. (2009). 18F- and 11C-labelling of quantum dots with n.c.a. [18F]fluoroethyltosylate and [11C]methyliodide: a feasibility study. Journal of Radioanalytical and Nuclear Chemistry. 283(2). 487–491. 7 indexed citations

14.

Schildan, Andreas, Marianne Patt, & Osama Sabri. (2007). Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380). Applied Radiation and Isotopes. 65(11). 1244–1248. 12 indexed citations

15.

Deuther‐Conrad, Winnie, J. T. Patt, Paul R. Lockman, et al.. (2007). Norchloro-fluoro-homoepibatidine (NCFHEB) — A promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET. European Neuropsychopharmacology. 18(3). 222–229. 19 indexed citations

16.

Sorger, Dietlind, Georg Becker, Andreas Schildan, et al.. (2007). Measurement of the α4β2* nicotinic acetylcholine receptor ligand 2-[18F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. Nuclear Medicine and Biology. 34(3). 331–342. 18 indexed citations

17.

Sorger, Dietlind, Georg Becker, Andreas Schildan, et al.. (2006). Binding properties of the cerebral α4β2 nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 to plasma proteins. Nuclear Medicine and Biology. 33(7). 899–906. 8 indexed citations

18.

Hesse, Swen, H.-J. Gertz, Christoph T. Zimmer, et al.. (2005). Cerebral nicotinic acetylcholine receptors (nAChRs) in patients with Alzheimer's disease (AD) or vascular dementia (VaD)- evaluation with 2-[18F]F-A85380 and positron emission tomography (PET). JuSER (Forschungszentrum Jülich). 2 indexed citations

19.

Deuther‐Conrad, Winnie, Andrea Wevers, Georg Becker, et al.. (2005). Autoradiography of 2‐[¹⁸F]F‐A‐85380 on nicotinic acetylcholine receptors in the porcine brain in vitro. Synapse. 59(4). 201–210. 10 indexed citations

20.

Meyer, Philipp, Kai Kendziorra, Swen Hesse, et al.. (2005). Quantitative assessment of the cerebral nicotinic acetylcholine receptors (nAChR) in Parkinson's disease using 2-[¹⁸F]F-A-85380-PET. Journal of Cerebral Blood Flow & Metabolism. 25(1_suppl). S321–S321. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact